Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Agilent Technologies
(NYSE:A)
Intraday
$132.73
0.29
[0.22%]
After-Hours
$132.73
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$132.73
0.29
[0.22%]
At close: Apr 19
$132.73
0
[0.00%]
After Hours: 4:20PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Agilent Technologies Stock (NYSE:A)
Agilent Technologies Stock (NYSE: A)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 15, 2024
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years
Benzinga Insights
-
4 days ago
Agilent Receives European IVDR Class C Certification For GenetiSure Dx Postnatal Assay
Benzinga Newsdesk
-
4 days ago
Wednesday, April 10, 2024
Barclays Maintains Underweight on Agilent Technologies, Raises Price Target to $135
Benzinga Newsdesk
-
Apr 10, 2024, 3:36PM
(A) - Analyzing Agilent Technologies's Short Interest
Benzinga Insights
-
Apr 10, 2024, 11:00AM
Friday, April 05, 2024
Stifel Upgrades Agilent Technologies to Buy, Raises Price Target to $163
Benzinga Newsdesk
-
Apr 5, 2024, 6:43AM
Thursday, April 04, 2024
Evercore ISI Group Maintains In-Line on Agilent Technologies, Raises Price Target to $145
Benzinga Newsdesk
-
Apr 4, 2024, 12:16PM
Monday, April 01, 2024
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $9,100 Today
Benzinga Insights
-
Apr 1, 2024, 3:00PM
Thursday, March 28, 2024
Agilent, Shoe Carnival And 2 Other Stocks Insiders Are Selling
Avi Kapoor
-
Mar 28, 2024, 8:21AM
Tuesday, March 26, 2024
A Glimpse Into The Expert Outlook On Agilent Technologies Through 6 Analysts
Benzinga Insights
-
Mar 26, 2024, 12:00PM
Inquiry Into Agilent Technologies's Competitor Dynamics In Life Sciences Tools & Services Industry
Benzinga Insights
-
Mar 26, 2024, 12:00PM
Oppenheimer Maintains Outperform on Agilent Technologies, Raises Price Target to $90
Benzinga Newsdesk
-
Mar 26, 2024, 10:00AM
Wednesday, March 20, 2024
Looking Into Agilent Technologies's Recent Short Interest
Benzinga Insights
-
Mar 20, 2024, 3:45PM
Wednesday, March 13, 2024
Top 7 Biotech Stock Winners As Weight Loss Drug Battle Escalates: Goldman Sachs Names Best Picks
Piero Cingari
-
Mar 13, 2024, 12:35PM
Friday, March 08, 2024
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $11,000 Today
Benzinga Insights
-
Mar 8, 2024, 1:30PM
Thursday, March 07, 2024
Bio-Techne: Commitment to Investor Contentment with Steadfast Earnings Performance
Benzinga Insights
-
Mar 7, 2024, 10:05AM
Thursday, February 29, 2024
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
Benzinga Insights
-
Feb 29, 2024, 9:00AM
Wednesday, February 28, 2024
Stocks Fall Ahead Of Fed's Inflation Data, UnitedHealth Sinks, Bitcoin Tops $61,000: What's Driving Markets Wednesday?
Piero Cingari
-
Feb 28, 2024, 2:08PM
Citigroup Maintains Neutral on Agilent Technologies, Raises Price Target to $145
Benzinga Newsdesk
-
Feb 28, 2024, 1:42PM
UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $155
Benzinga Newsdesk
-
Feb 28, 2024, 1:19PM
Assessing Agilent Technologies: Insights From 6 Financial Analysts
Benzinga Insights
-
Feb 28, 2024, 1:00PM
Evercore ISI Group Maintains In-Line on Agilent Technologies, Lowers Price Target to $132
Benzinga Newsdesk
-
Feb 28, 2024, 12:06PM
Barclays Maintains Underweight on Agilent Technologies, Raises Price Target to $125
Benzinga Newsdesk
-
Feb 28, 2024, 11:06AM
Agilent shares are trading higher after the company reported better-than-expected Q1 financial results.
Benzinga Newsdesk
-
Feb 28, 2024, 8:25AM
Nasdaq, S&P 500 Futures Decline As Traders Await GDP Data, Fed Speeches; Bitcoin Eyes $60K Milestone: Analysts Highlight Small-Cap Gains As Sign Of Robust Economy
Shanthi Rexaline
-
Feb 28, 2024, 6:08AM
Tuesday, February 27, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Feb 27, 2024, 4:31PM
Agilent shares are trading higher after the company reported better-than-expected Q1 financial results.
Benzinga Newsdesk
-
Feb 27, 2024, 4:10PM
Agilent Technologies Q1 2024 Adj EPS $1.29 Beats $1.22 Estimate, Sales $1.66B Beat $1.59B Estimate
Benzinga Newsdesk
-
Feb 27, 2024, 4:06PM
S&P 500, Nasdaq 100 Dip, Small Caps Surge; Bitcoin Tops $57,000, 2 Biotech Stocks Skyrocket: What's Driving Markets Tuesday?
Piero Cingari
-
Feb 27, 2024, 2:18PM
Nasdaq, S&P 500 Futures Grind Higher After Pause, Bitcoin Tops $56K: Analyst Spotlights 'Big Takeaway' That Augurs Well For Market
Shanthi Rexaline
-
Feb 27, 2024, 5:49AM
Earnings Scheduled For February 27, 2024
Benzinga Insights
-
Feb 27, 2024, 5:01AM
Monday, February 26, 2024
Bio-Techne: Bolstering Investor Value with Reduced Dividends and Amplified Earnings
Benzinga Insights
-
Feb 26, 2024, 10:05AM
Wednesday, February 21, 2024
Agilent CEO Mike McMullen To Retire; Agilent CrossLab Group President Padraig McDonnell Named CEO-Elect And Chief Operating Officer
Happy Mohamed
-
Feb 21, 2024, 5:00PM
Tuesday, February 13, 2024
$100 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today
Benzinga Insights
-
Feb 13, 2024, 12:00PM
Thursday, February 01, 2024
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years
Benzinga Insights
-
Feb 1, 2024, 1:30PM
Tuesday, January 30, 2024
Agilent Collaborates With Incyte; Enables Agilent To Expand Companion Diagnostics Portfolio; Incyte Leverages Agilents Expertise In IVD Assay Development
Benzinga Newsdesk
-
Jan 30, 2024, 8:02AM
Friday, January 26, 2024
Shares of lifesciences and medical equipment stocks are trading higher following strong earnings from Sartorius.
Benzinga Newsdesk
-
Jan 26, 2024, 1:00PM
Thursday, January 25, 2024
Expert Ratings For Agilent Technologies
Benzinga Insights
-
Jan 25, 2024, 11:00AM
Barclays Maintains Underweight on Agilent Technologies, Raises Price Target to $120
Benzinga Newsdesk
-
Jan 25, 2024, 9:40AM
Wednesday, January 24, 2024
Agilent Technologies Demonstrates Strong Performance and Increased Profits, Maximizing Returns for Shareholders
Benzinga Insights
-
Jan 24, 2024, 10:05AM
Monday, January 22, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Jan 22, 2024, 12:35PM
Wednesday, January 17, 2024
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion
Vandana Singh
-
Jan 17, 2024, 3:21PM
Friday, January 05, 2024
Here's How Much $1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth Today
Benzinga Insights
-
Jan 5, 2024, 2:30PM
Thursday, December 28, 2023
Looking Into Agilent Technologies's Recent Short Interest
Benzinga Insights
-
Dec 28, 2023, 3:00PM
Wednesday, December 20, 2023
JP Morgan Maintains Overweight on Agilent Technologies, Raises Price Target to $165
Benzinga Newsdesk
-
Dec 20, 2023, 2:53PM
$100 Invested In This Stock 15 Years Ago Would Be Worth $900 Today
Benzinga Insights
-
Dec 20, 2023, 9:00AM
Agilent Technologies Moved The Company's Cell Analysis Division Into Its Diagnostics And Genomics Group As Part Of A Strategy To Further Strengthen Growth Opportunities For Both Organizations
Benzinga Newsdesk
-
Dec 20, 2023, 9:00AM
Wednesday, December 13, 2023
Wolfe Research Initiates Coverage On Agilent Technologies with Outperform Rating
Benzinga Newsdesk
-
Dec 13, 2023, 12:56PM
Tuesday, December 12, 2023
Analyst Ratings for Agilent Technologies
Benzinga Insights
-
Dec 12, 2023, 10:00AM
B of A Securities Downgrades Agilent Technologies to Neutral, Raises Price Target to $133
Benzinga Newsdesk
-
Dec 12, 2023, 8:04AM
Thursday, December 07, 2023
Goldman Sachs Maintains Buy Rating for Agilent Technologies: Here's What You Need To Know
Benzinga Insights
-
Dec 7, 2023, 12:00PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch